Summary:
Do you have multiple sclerosis with spasticity?
Meridien Research is conducting a clinical research study of an investigational multiple sclerosis (MS) medication. All studies are administered by a board certified physician in cooperation with your primary care physician.
Qualified Participants Must:
If you are 18 years of age or older with spasticity due to multiple sclerosis (and are on a stable dose of Baclofen), you may be eligible to participate.
Qualified Participants May Receive:
Evaluations, physical exams, routine lab work and Investigational medication or placebo at no cost. Compensation for time and travel may be available.